ClariVest Asset Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$1.01M	Hold	20,020	–	–	0.1%	260
2024 Q2	$1.01M	Buy	20,020 +1,146	+6%	+$57.6K	0.1%	260
2024 Q1	$2.11M	Buy	+18,874	New	+$2.11M	0.22%	127